Team
Visit the page
AmorChem 1
Portfolio
Visit the page
AmorChem 1
Community
Collaboration
Visit the page
AmorChem 1
News
EN
FR
Menu
February 15, 2023
AmorChem Promotes Dr. Kevin McBride to General Partner
Read article
March 15, 2022
Inversago Pharma Announces Dosing of First Participant with Metabolic Syndrome in Phase 1B Clinical Trial
Read article
January 12, 2022
CQDM partners with Neurasic Therapeutics, HBHL and the Louise and Alan Edwards Foundation to fund a non-opioid pain treatment discovery
Read article
May 19, 2021
Giiant Pharma Inc. announced the closing of US$11M in Seed financing to develop its Precision Delivery technology platform in gastroenterology.
Read article
June 4, 2020
AmorChem invests in a potential treatment for cerebral amyloid angiopathy and Alzheimer’s disease
Read article
June 3, 2020
AmorChem invests in the work of Sidong Huang at McGill University
Read article
May 12, 2020
Consortium Backs Netherton Syndrome Project From Sinai Health
Read article
February 24, 2020
AmorChem invests in a new gene therapy approach to help patients with a devastating orphan disease
Read article
March 18, 2019
Announcement of Sweet 16 Selection for the 1st edition of Sweet Pharma Day
Read article
News archive